FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:624.000000|Direction: 1|PValue:0.019901043|FDR:0.17289031;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:  6.702928|Direction: 1|PValue:0.035033022|FDR:0.30448322;FeatureName:residual_tumor|Type:CAT|StatisticMethod:kruskal|GroupComparison:r0/r2/rx/r1|Statistics: 12.119585|Direction: 1|PValue:0.006984540|FDR:0.16022951;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics: 11.437579|Direction: 1|PValue:0.009580443|FDR:0.12780522;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:281.000000|Direction:-1|PValue:0.013653766|FDR:0.05271871;FeatureName:KRAS_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics:671.000000|Direction:-1|PValue:0.046346288|FDR:0.42947561;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:386.000000|Direction:-1|PValue:0.011183076|FDR:0.05757213;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:317.000000|Direction:-1|PValue:0.033442401|FDR:0.20210842;FeatureName:DCHS2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:187.000000|Direction:-1|PValue:0.010543399|FDR:0.26468118;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.386036|Direction:-1|PValue:0.000203497|FDR:0.00108793;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.344786|Direction:-1|PValue:0.001003238|FDR:0.00464833;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.222320|Direction:-1|PValue:0.037355391|FDR:0.19970767;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.317876|Direction:-1|PValue:0.002544522|FDR:0.01040260;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.283808|Direction:-1|PValue:0.007370417|FDR:0.02561220;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.390267|Direction: 1|PValue:0.000170671|FDR:0.00184855;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.320069|Direction: 1|PValue:0.002365960|FDR:0.01096228;FeatureName:17p12_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.228023|Direction: 1|PValue:0.032622511|FDR:0.14170403;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.290513|Direction: 1|PValue:0.006036810|FDR:0.02622239